191613-39-5

Upstream product

• 117299-90-8 allyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-α-D-galactopyranoside 
• 64650-83-5 N-((2S,3R,4R,5R,6R)-2-Allyloxy-4,5-dihydroxy-6-hydroxymethyl-tetrahydro-pyran-3-yl)-acetamide 
• 72-87-7 N-acetyl-D-galactosamine 

Downstream Products

• 191613-40-8 {Benzyl-[2-((2S,3R,4R,5R,6R)-4,5-diacetoxy-6-acetoxymethyl-3-acetylamino-tetrahydro-pyran-2-yloxy)-ethyl]-amino}-acetic acid tert-butyl ester 
• 191613-46-4 C₄₈H₆₈N₄O₂₃ 
• 191613-48-6 C₄₄H₆₀N₄O₂₃ 
• 191613-42-0 {Benzyloxycarbonyl-[2-((2S,3R,4R,5R,6R)-4,5-diacetoxy-6-acetoxymethyl-3-acetylamino-tetrahydro-pyran-2-yloxy)-ethyl]-amino}-acetic acid tert-butyl ester 
• 191613-43-1 {Benzyloxycarbonyl-[2-((2S,3R,4R,5R,6R)-4,5-diacetoxy-6-acetoxymethyl-3-acetylamino-tetrahydro-pyran-2-yloxy)-ethyl]-amino}-acetic acid 

Relevant academic research and scientific papers

Oligomeric glycopeptidomimetics bearing the cancer related T(N)-antigen

α-O-Linked N-acelylgalactosamine clusters with 2, 3, 4, 6, and 8 repenting units were synthesized using a reiterative blockwise appronch and N-substituted oligoglycine peptoid backbones. Orthogonally protected glycopeptide 5 and 7 were used as key building blocks.